Features & Compatibility
Semaglutide is a GLP-1 analogue and GLP-1 receptor agonist that selectively binds to and activates GLP-1 receptors. It is widely used in laboratory research involving glucose metabolism, insulin signaling, appetite regulation, energy balance, and other related metabolic mechanisms.
Its selective receptor activity makes Semaglutide a useful reference compound for studying GLP-1–mediated biological pathways in controlled research environments. FDA reference
Variants:
5mg10vials | 15mg10vials | 20mg10vials | 30mg10vials | 40mg10vials | 50mg10vials
For laboratory research use only. Not intended for human consumption or therapeutic use.
Customer Reviews
Related Products
Glow
Glow is a three-component research peptide blend combining BPC-157, GHK-Cu and TB-500. The formula is designed for laboratory studies involving
Ipamorelin
Ipamorelin is a synthetic peptide and selective growth hormone secretagogue receptor (GHS-R) agonist. It is studied for its ability to
LYSINE-PROLINE-VALINE(KPV)
KPV is a short tripeptide composed of Lysine, Proline and Valine. It represents the C-terminal amino-acid sequence of alpha-melanocyte-stimulating hormone
NAD+
NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme naturally present in living cells. It plays a central role in cellular
Retatrutide
Retatrutide, also known as LY3437943, is an investigational peptide designed to act on three metabolic hormone receptors: GIP, GLP-1, and
Semax
Semax is a synthetic heptapeptide composed of an ACTH (4–7) fragment combined with the Pro-Gly-Pro (PGP) sequence. It is studied

Reviews
There are no reviews yet.